![Sascha Przybilla](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sascha Przybilla
Nessuna posizione attualmente
Profilo
Sascha Przybilla is currently the Managing Director at bioMérieux Deutschland GmbH.
Precedenti posizioni note di Sascha Przybilla
Società | Posizione | Fine |
---|---|---|
bioMérieux Deutschland GmbH
![]() bioMérieux Deutschland GmbH Medical SpecialtiesHealth Technology Part of Compagnie Merieux Alliance SAS, bioMérieux Deutschland GmbH is a diagnostic solutions company based in Nurtingen, Germany. bioMérieux provides in vitro diagnostic solutions, including reagents, instruments, software, and services, to determine the source of disease and contamination to improve patient health and ensure consumer safety. The German company is committed to ensuring the quality and safety of food products through rapid, sensitive, and proven microbiological testing solutions. Additionally, bioMérieux offers Predictive Diagnostics to help move away from detecting and responding to issues, to predicting and preventing them. The company develops, produces, and distributes diagnostic solutions for use in the medical or industrial sector. The company was founded in 1963 by Alain Mérieux and the CEO is Sascha Przybilla. | Amministratore Delegato | 31/03/2021 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
bioMérieux Deutschland GmbH
![]() bioMérieux Deutschland GmbH Medical SpecialtiesHealth Technology Part of Compagnie Merieux Alliance SAS, bioMérieux Deutschland GmbH is a diagnostic solutions company based in Nurtingen, Germany. bioMérieux provides in vitro diagnostic solutions, including reagents, instruments, software, and services, to determine the source of disease and contamination to improve patient health and ensure consumer safety. The German company is committed to ensuring the quality and safety of food products through rapid, sensitive, and proven microbiological testing solutions. Additionally, bioMérieux offers Predictive Diagnostics to help move away from detecting and responding to issues, to predicting and preventing them. The company develops, produces, and distributes diagnostic solutions for use in the medical or industrial sector. The company was founded in 1963 by Alain Mérieux and the CEO is Sascha Przybilla. | Health Technology |
- Borsa valori
- Insiders
- Sascha Przybilla